-
The adjustment of the medical insurance catalogue starts!
Time of Update: 2021-07-28
In the expert review stage, the National Medical Insurance Bureau will demonstrate the expert opinions of the professional group, and finally determine the list of drugs in five aspects: direct transfer, negotiation transfer, direct transfer, can transfer, and adjust the limited payment scope .
-
Zhong Nanshan talks about mutant virus strains: the establishment of an immune barrier is imminent
Time of Update: 2021-07-28
"This time, due to the high viral load and highly infectious characteristics of the delta strain, as long as the patient was in the same space, unit, and building 4 days before the onset of illness, they were considered close contacts .
-
Experts remind to beware of "air conditioning disease" prevention is greater than cure
Time of Update: 2021-07-28
Jiang Wei, an expert in the Department of Critical Care Medicine of Shanghai Tenth People's Hospital, said in an interview on the 20th that "air-conditioning disease" is a variety of human symptoms caused by improper use of air-conditioning .
-
Ultra-thin spinal implants can help treat stubborn pain
Time of Update: 2021-07-28
According to a paper recently published in the journal "Science Advances", researchers at the University of Cambridge in the United Kingdom combined soft robotics manufacturing technology, ultra-thin electronics and microfluidic technology to develop an ultra-thin inflatable device that can treat the most severe limb pain , Such as leg and back pain that cannot be cured by painkillers, without the need for invasive surgery .
-
Health Commission: 14 newly diagnosed cases on the 26th, all imported from abroad
Time of Update: 2021-07-28
As of 24:00 on June 26, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 462 confirmed cases (including 13 severe cases), 86,634 cured and discharged cases, and 4,636 deaths.
-
Zhong Nanshan: Artificial Intelligence "Breaking Out" Helping Epidemic Prevention and Control
Time of Update: 2021-07-28
Zhong Nanshan said that the new generation of information technology such as artificial intelligence has empowered the medical, health, and public health fields, promoted the global basic medical research, clinical application research, and the research and development of pharmaceutical devices, and further enhanced human cognition and understanding of diseases .
-
Comparative analysis and diagnosis model establishment of membranous nephropathy and other types of nephropathy
Time of Update: 2021-07-28
The non-invasive diagnostic model established in this study through Logistic regression analysis can effectively diagnose membranous nephropathy with high sensitivity and specificity, and has a wide range of clinical application potential .
-
Hengrui Class 1 new drug is close to NDA, what signals have it released
Time of Update: 2021-07-28
Not long ago, the CDK4/6 inhibitor SHR6390 developed by Jiangsu Hengrui has been submitted to the domestic NDA for breast cancer; and 1 month ago, this product was also included in the breakthrough treatment program of CDE, and the indication was combined with fluorine.
-
The data said: The second round of centralized procurement was implemented for one year, what impact did it bring to the market, and why did the volume and price of generic drugs fall?
Time of Update: 2021-07-28
Using the sales data analysis in 2020 (refer to the admission price of IMS), the total sales of more than 30 varieties selected in the second round of centralized procurement will be 29.
503 billion doses, and the total sales of generic drugs fell from 18.
-
Delicious food hides "three highs" risks
Time of Update: 2021-07-28
Xu Jiao, director of the Food and Nutrition Division of the Food Safety Standards and Monitoring and Evaluation Department of the National Health Commission, said that high salt, high oil, and high sugar intake are risk factors for obesity, cardiovascular and cerebrovascular diseases, diabetes and other metabolic diseases and cancer.
-
Hengrui tops the list!
Time of Update: 2021-07-28
27 billion yuan, an increase of 44% year-on-year, accounting for 55% of total revenue, and its gross profit margin reached 93%, the highest among all businesses .
Source: Hengrui Annual Report to sum up To a certain extent, the revenue of anti-tumor products represents the innovation ability of pharmaceutical companies.
-
Popular Science: What is the Delta Strain of New Coronary Mutant Virus
Time of Update: 2021-07-28
The World Health Organization said on the 21st that the delta strain of the new crown virus has now spread to 92 countries .
However, experts in many countries believe that the current vaccination is still effective, at least it can prevent severe illness and reduce deaths .
-
The vaccination rate continues to increase, and it will become easier and easier to deal with the virus
Time of Update: 2021-07-28
Zhang Wenhong said that "Delta" is currently the fastest virus in the world, but no matter how fast it runs, it is still a coronavirus and has not become a new virus.
Zhang Wenhong emphasized that this means that the original prevention and control measures against the virus are still effective, including vaccination .
-
Of the world's TOP10 generic drug companies, India has five seats, none of which are from China!
Time of Update: 2021-07-28
Allergan's generic drug business acquired by Teva was renamed through continuous mergers and acquisitions by Watson Pharmaceuticals, the third largest generic drug company in the United States .
-
New research finds that pollen can also transmit the new coronavirus
Time of Update: 2021-07-28
map The researchers calculated all the pollen-producing parts of the willow tree and simulated outdoor gatherings of about 10 to 100 people, some of whom COVID-19 patients would transmit virus particles .
-
New research: mRNA COVID-19 vaccine can induce long-lasting immune response
Time of Update: 2021-07-28
A study published online a few days ago on the website of the British journal Nature showed that nearly 4 months after the first dose of vaccination, the immune response induced by the mRNA (messenger ribonucleic acid) new crown vaccine is still active .
-
In 2020, it will sell for 1.776 billion U.S. dollars, and AstraZeneca Olapali will be approved for new indications in China
Time of Update: 2021-07-28
In December 2019, the drug was approved by the NMPA for first-line platinum-based chemotherapy in newly-treated adult patients with germline or somatic BRCA mutations (gBRCAm or sBRCAm) advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer Maintenance treatment after complete remission or partial remission is achieved .
-
Zhong Nanshan's team: Intelligent throat swab robot can meet the needs of large-scale
Time of Update: 2021-07-28
Academy of Sciences According to reports, the second-generation intelligent pharyngeal swab collection robot is oriented to the needs of intelligent large-scale collection, and has the characteristics of realizing remote semi-automatic operation and reducing the risk of doctor-patient cross-over .
-
Top ten pharmaceutical companies accelerate R&D strategy adjustment
Time of Update: 2021-07-28
Combination of investment transactions and asset divestiture activities in the first quarter In recent years, with the rapid development of innovative biotechnology companies, large global pharmaceutical companies have launched cooperation models such as acquisitions and investments to quickly supplement their new drug R&D pipelines .
-
The centralized procurement of injections is speeding up, and how much pressure is there for the provincial alliance and national procurement to cut prices?
Time of Update: 2021-07-28
From the perspective of the included varieties, according to the combing, there are 9 varieties of felodipine, torasemide, fluorouracil, ozagrel sodium, iron sucrose injection, lidocaine, calcitriol, tranexamic acid, and argatroban It is the first time to participate in provincial-level mass procurement, or it is expected to refresh the national lowest price of corresponding drugs .
